Ola Rizq, Naoya Mimura, Motohiko Oshima, Atsunori Saraya, Shuhei Koide, Yuko Kato, Kazumasa Aoyama, Yaeko Nakajima-Takagi, Changshan Wang, Tetsuhiro Chiba, et al. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition. Clinical Cancer Research. 2017. 23. 16. 4817-4830
Y Nishida, A Maeda, M J Kim, L Cao, Y Kubota, J Ishizawa, A AlRawi, Y Kato, A Iwama, M Fujisawa, et al. The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells. Blood Cancer Journal. 2017. 7. 2. e527-e527
Ola Rizq, Naoya Mimura, Motohiko Oshima, Atsunori Saraya, Shuhei Koide, Yuko Kato, Kazumasa Aoyama, Yaeko Nakajima-Takagi, Changshan Wang, Anqi Ma, et al. Molecular Mechanism behind the Synergistic Activity of Proteasome Inhibition and PRC2 Inhibition in the Treatment of Multiple Myeloma. BLOOD. 2016. 128. 22
Lectures and oral presentations (3):
Bmi1 restricts the adipogenic differentiation of mesenchymal stromal cells to maintain the integrity of the hematopoietic stem cell niche
(2019)
造血幹細胞ニッチにおけるBmi1の機能解析
(第40回日本炎症・再生医学会 2019)
The polycomb protein Bmi1 restrains perivascular mesenchymal stromal cells from adipogenic differentiation to maintain the integrity of hematopoietic stem cell niche
(2018)